Author:
Kremenchutzky M.,Rice G. P. A.,Baskerville J.,Wingerchuk D. M.,Ebers G. C.
Publisher
Oxford University Press (OUP)
Reference60 articles.
1. Achiron A, Pras E, Gilad R, Ziv I, Mandel M, Gordon C, et al. Open controlled therapeutic trial of intravenous immune globulin in relapsing-remitting multiple sclerosis. Arch Neurol1992; 49: 1233–6.
2. Andersson PB, Waubant E, Gee L, Goodkin DE. Multiple sclerosis that is progressive from the time of onset: clinical characteristics and progression of disability. Arch Neurol1999; 56: 1138–42.
3. Bornstein MB, Miller A, Slagle S, Weitzman M, Drexler E, Keilson M, et al. A placebo-controlled, double-blind, randomized, two-center, pilot trial of Cop 1 in chronic progressive multiple sclerosis. Neurology1991; 41: 533–9.
4. Coles AJ, Paolillo A, Molyneux P, Wing M, Hale G, Miller D, et al. Monoclonal antibody treatment exposes three mechanisms underlying the clinical course of multiple sclerosis. Ann Neurol1998; 44: 464.
5. Coles AJ, Wing MG, Molyneux P, Paolillo A, Davie CM, Hale G, et al. Monoclonal antibody treatment exposes three mechanisms underlying the clinical course of multiple sclerosis. Ann Neurol1999; 46: 296–304.
Cited by
378 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献